Skip to main content

Latest SEC Filings — Page 120

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Vireo Growth to Acquire FLUENT Corp. in All-Stock Transaction, Expanding Florida Footprint
ProForm 8-KVREOF · Form 8-K · 3d ago
SPAC Discloses Substantial Doubt About Going Concern Amid Dwindling Operating Cash
ProForm 10-QSCPQ · Form 10-Q · 3d ago
Hinge Health Reports Strong Q1 Results, Raises Full-Year Outlook, and Executes Share Repurchase
ProForm 8-KHNGE · Form 8-K · 3d ago
Dianthus Therapeutics Secures $777.7M in Capital, Extends Runway to 2030, and Receives Orphan Drug Designation
ProForm 10-QDNTH · Form 10-Q · 3d ago
Jazz Pharma Reports Strong Q1, Zanidatamab sBLA Granted Priority Review with August PDUFA
ProForm 8-KJAZZ · Form 8-K · 3d ago
Medallion Financial Reports Sharp Q1 Earnings Decline Amidst Regulatory Default and Lower Equity Gains
ProForm 10-QMFIN · Form 10-Q · 3d ago
AES Corp Reports Strong Q1 2026 Results Amidst Ongoing Merger Process, Advances Regulatory Approvals
ProForm 10-QAES · Form 10-Q · 3d ago
Director's Stake in ZW Data Action Technologies Rises to 7.1% Following Share Award
Form SCHEDULE 13DCNET · Form SCHEDULE 13D · 3d ago
Ultragenyx Reports Q1 Revenue Miss, Reaffirms Guidance, Advances Multiple Gene Therapy Programs
Form 8-KRARE · Form 8-K · 3d ago
Credit Acceptance Reports Strong Q1 Earnings, Secures $450M Financing, Updates Legal Settlement
ProForm 10-QCACC · Form 10-Q · 3d ago
Cytokinetics Reports Positive Phase 3 ACACIA-HCM Results, First MYQORZO Sales, and Q1 Financials
ProForm 10-QCYTK · Form 10-Q · 3d ago
Activist Investor HoldCo Asset Management Discloses 5.1% Stake in Capitol Federal Financial, Plans Engagement for Shareholder Value
ProForm SCHEDULE 13DCFFN · Form SCHEDULE 13D · 3d ago
Emerson Reports Mixed Q2 Results, Updates 2026 Outlook, and Appoints New Director
Form 8-KEMR · Form 8-K · 3d ago
Activist Nominee Rory Held Elected to Ingles Markets Board
ProForm 8-KIMKTA · Form 8-K · 3d ago
EverQuote Reports Strong Q1 2026 Results with Significant Profit Growth and Continued Share Repurchases
ProForm 10-QEVER · Form 10-Q · 3d ago
Onto Innovation Reports In-Line Q1 Results, Issues Q2 Guidance, and Announces $710M Strategic Investment in Rigaku
ProForm 8-KONTO · Form 8-K · 3d ago
G-III Apparel Seeks Shareholder Approval for Expanded Equity Plan Amid Strategic Shift
ProForm DEF 14AGIII · Form DEF 14A · 3d ago
Grayscale Ethereum Classic Trust Reports 29% Net Asset Decline in Q1 2026 Amid ETC Price Drop
ProForm 10-QETCG · Form 10-Q · 3d ago
Tempus AI Reports Mixed Q1 2026 Results with Widened Net Loss and Significant CEO Selling Plan
ProForm 10-QTEM · Form 10-Q · 3d ago
GRAIL Reports Strong Q1 Revenue Growth, Reduced Losses, and Key Progress on FDA Approval & Epic EHR Integration
ProForm 8-KGRAL · Form 8-K · 3d ago
Saratoga Investment Corp. Reports Annual Results with NAV Decline, Significant Cash Reduction, and Active Debt Refinancing
Form 10-KSAR · Form 10-K · 3d ago
Annual Meeting Set; Co-Founder Pledges $106.7M in Shares Amid Strong FY26 Performance
Form DEF 14ATTAN · Form DEF 14A · 3d ago
Bumble Reports Strong Q1 Profitability Turnaround, Exceeding Expectations with $52.6M Net Earnings
ProForm 8-KBMBL · Form 8-K · 3d ago
Q1 Net Income Declines, Lilly Collaboration Terminated, Debt Restructured
ProForm 10-QRIGL · Form 10-Q · 3d ago
Navitas Semiconductor Reports Mixed Q1 Results, Guides for Sequential Growth Amid Strategic Pivot
ProForm 8-KNVTS · Form 8-K · 3d ago
Donnelley Financial Solutions Reports Strong Q1 2026 Results with Increased Earnings and Improved Cash Flow
Form 10-QDFIN · Form 10-Q · 3d ago
IDEAYA Biosciences Reports Q1 2026 Financials, Highlights Positive Darovasertib Phase 2/3 Data and New AstraZeneca Collaboration
ProForm 10-QIDYA · Form 10-Q · 3d ago
BJ's Restaurants Reports Strong Q1 2026 Results with Sales & Traffic Growth, Reiterates Full-Year Outlook
ProForm 8-KBJRI · Form 8-K · 3d ago
Perceptive Capital Seeks Shareholder Approval to Extend Merger Deadline to June 2027, Averting Liquidation
ProForm PRE 14APCSC · Form PRE 14A · 3d ago
Scilex Amends Proxy to Ease Passage of Dilutive Share Increase Proposal
Form DEFA14ASCLX · Form DEFA14A · 3d ago